Entrepreneurs April 22, 2021 The man who believed that work can create happiness Businessman and Tec graduate Simón Cohen suffered from a heart condition that led him to seek happiness instead of success.
Education April 21, 2021 PrepaTec Colima wins Safety Animation Award at FIRST Robotics PrepaTec Colima’s HORUS 6348 team has won the 2021 Safety Animation Award and is the first Latin American team to achieve this accomplishment.
Institution April 19, 2021 Tec and University of Illinois to design furniture trends Tec de Monterrey and the University of Illinois will exchange proposals on innovative and flexible furniture design for the new normal.
Art & Culture April 19, 2021 NYT says Mexican architect among 10 leading women to follow The New York Times has recognized outstanding architect Fernanda Canales as one of the most influential female leaders in the world.
Research April 06, 2021 EGADE circular economy project gains worldwide recognition SWIT, a circular economy project from an EGADE Business School professor, has been recognized by the Association to Advance Collegiate Schools of Business.
Research March 26, 2021 Tec professor gives talk at MIT SCALE Latin America Conference A professor from Tecnológico de Monterrey gave a talk about the coexistence of “nanostores” in the retail ecosystem at the MIT SCALE Latin America Conference.
Institution March 18, 2021 Tec Review is 2021 SPD Awards finalist Tec Review magazine is a finalist for the 56th Society of Publication Designers awards, which recognize the best editorial design from around the world.
Education February 24, 2021 Public Participation: why me? (Op-Ed by Juan Pablo Murra) Juan Pablo Murra, Rector of Undergraduate and Graduate Studies at Tecnológico de Monterrey, reflects on the importance of public participation as a cornerstone towards building the ethos of a common good.
Health February 17, 2021 TecSalud begins Phase 3 trials of German CureVac vaccine in Mexico TecSalud has started administering the vaccine candidate from German pharmaceutical company CureVac for its Phase 3 clinical trials.
